{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-25-000611","form_type":"8-K","ticker":"SNOA","cik":"0001367083","company_name":"Sonoma Pharmaceuticals, Inc.","filed_at":"2025-01-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.441578+00:00","generated_at":"2026-05-27T05:13:01.646252+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Sonoma inks exclusive US distribution deal with WellSpring for Microcyn products","bullets":["Exclusive US distribution agreement with WellSpring Pharmaceutical, effective Jan 29, 2025.","Initial term of 2 years with three automatic one-year renewal periods.","WellSpring to distribute Microcyn-based products through defined channels; Sonoma retains all IP.","WellSpring must use commercially reasonable efforts and cannot sell competing hypochlorous acid products in those channels.","Pricing, minimum quantities, and forecasts are set in confidential attachments."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-25-000611","json":"https://secwatch.observer/filing/0001683168-25-000611.json","markdown":"https://secwatch.observer/filing/0001683168-25-000611.md","text":"https://secwatch.observer/filing/0001683168-25-000611.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1367083/000168316825000611/0001683168-25-000611-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1367083/000168316825000611/sonoma_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T05:13:01.646252+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}